Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.78 |
| ▸ | RORC | P51449 | 1/20 | 0.66 |
| ▸ | NPC1 | O15118 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.65 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.62 |
| ▸ | MLYCD | O95822 | 1/20 | 0.61 |
| ▸ | SNCA | P37840 | 1/20 | 0.61 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.59 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.59 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.59 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.59 |
| ▸ | AHR | P35869 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7748386 | 0.85 | KMT2A (0.67) | MEN1KMT2ANPC1MAPTALDH1A1 | |
| SCHEMBL13561219 | 0.84 | MEN1 (0.76) | MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3528493 | 0.84 | EPHX1 (0.78) | MEN1KMT2ANPC1MAPTALDH1A1 | |
| SCHEMBL29886513 | 0.84 | EPHX1 (0.78) | MEN1KMT2ANPC1MAPTALDH1A1 | |
| SCHEMBL8308004 | 0.83 | MEN1 (0.69) | MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL2033537 | 0.83 | MEN1 (0.74) | MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL4254980 | 0.83 | TP53 (0.75) | MEN1KMT2AMAPTALDH1A1SNCA | |
| SCHEMBL8713312 | 0.83 | MEN1 (0.81) | MEN1KMT2ANPC1MAPTALDH1A1 | |
| Iodide SCHEMBL30758664 | 0.83 | EPHX1 (0.77) | MEN1KMT2ANPC1MAPTALDH1A1 | |
| SCHEMBL13265686 | 0.83 | MEN1 (0.65) | MEN1KMT2ARORCMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0620122-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1996-03-13 | — | — | EP | claimed |
| US-5446010-A | Substrate sheet, thermosensitive colored image forming layer containing colorless dye precursor, binder, color developing agent having sulfonylureido group, aromatic amide sensitizer; storage stability | NEW OJI PAPER CO., LTD. (JP) | 1995-08-29 | — | — | US | claimed |
| EP-0620122-A1 | Thermosensitive recording material | NEW OJI PAPER CO., LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| US-9023340-B2 | Wnt inhibitors for human stem cell differentiation | CHEMREGEN, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| CN-102224423-B | Ligands for aggregated tau molecules | WISTA LABORATORIES LTD. (SG) | 2014-10-22 | — | — | CN | disclosed |
| US-20130177535-A1 | WNT INHIBITORS FOR HUMAN STEM CELL DIFFERENTIATION | CHEMREGEN, INC | 2013-07-11 | — | — | US | disclosed |
| US-6211242-B1 | CARDIOVASCULAR DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0757670-B1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 1999-01-13 | — | — | EP | disclosed |
| US-5728835-A | HYPOTENSIVE AGENTS; ANTIISCHEMIC AGENTS | TOA EIYO, LTD. (JP) | 1998-03-17 | — | — | US | disclosed |
| EP-0757670-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-12 | — | — | EP | disclosed |
| EP-0620122-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1996-03-13 | — | — | EP | disclosed |
| WO-1995029152-A1 | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-11-02 | — | — | WO | disclosed |
| US-5446010-A | Substrate sheet, thermosensitive colored image forming layer containing colorless dye precursor, binder, color developing agent having sulfonylureido group, aromatic amide sensitizer; storage stability | NEW OJI PAPER CO., LTD. (JP) | 1995-08-29 | — | — | US | disclosed |
| EP-0661266-A1 | Substituted cyclic amine compounds as 5HT2 antagonists | TOA EIYO LTD. (JP) | 1995-07-05 | — | — | EP | disclosed |
| EP-0620122-A1 | Thermosensitive recording material | NEW OJI PAPER CO., LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130177535-A1 | WNT INHIBITORS FOR HUMAN STEM CELL DIFFERENTIATION | WNT3A, WNT1, WNT3 | MEN1 2567/4885KMT2A 2473/4885RORC 334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.